CANADA: Pregnant Women at Risk for HIV May Opt Out of Testing

Important note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.

CANADA: Pregnant Women at Risk for HIV May Opt Out of Testing

Reuters Health (12.24.07) - Friday, December 28, 2007

Women in prenatal care who chose not to be screened for HIV were more likely to be infected than those who opted to be tested, according to a new Canadian study.

In a review of more than 110,000 women in Alberta receiving prenatal infectious-disease screening from 2002 to 2004, fewer than 4 percent opted out of HIV testing, reported University of Alberta's Dr. Ameeta E. Singh and associates.

Reasons for opting out could not be determined, as the identities of women were unknown at the time of analysis, the team said. However, newly diagnosed HIV prevalence among the opt-out group was 3.3 times greater than those who were tested (0.07 percent vs. 0.02 percent), the authors report.

"This may indicate that women at higher risk for HIV infection are opting out of testing," the investigators wrote. "HIV testing in pregnancy is essential to improving health care for HIV-infected women and to prevent mother-to-child transmission of HIV," said Singh. "Anything less than truly universal HIV testing in pregnant women is likely to result in missed opportunities to prevent mother-to-child transmission of HIV."

The full report, "HIV Seroprevalence Among Women Opting Out of Prenatal HIV Screening in Alberta, Canada: 2002-2004," was published in Clinical Infectious Diseases (2007;45(12):1640- 1643).
071228
AD072696

Copyright © 2007 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.